Detection and pharmacokinetics of tetrahydrogestrinone in horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 2, 2009, Pages 197-202

  MacHnik, M ^a,d   Gerlach, M ^b   Kietzmann, M ^b   Niedorf, F ^b   Thevis, M ^d   Schenk, I ^d   Guddat, S ^d   DUe M ^c   SchAnzer W ^d  

^a University of Veterinary Medicine Hannover ^*  (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c Federation Equestre Nationale (FN)   (Germany)

^d GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TETRAHYDROGESTRINONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG SELECTIVITY; HALF LIFE TIME; HORSE; HYDROLYSIS; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; SOLVOLYSIS; TANDEM MASS SPECTROMETRY; URINALYSIS;

ANIMALS; DOPING IN SPORTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GESTRINONE; HALF-LIFE; HORSES; MALE; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EQUIDAE;

EID: 61849120360     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.01021.x     Document Type: Article

References (17)

1. Catlin, D.H., Sekera, M.H., Ahrens, B.D., Starcevic, B., Chang, Y. Hatton, C.K. (2004) Tetrahydrogestrinone: dicovery, synthesis, and detection in urine. Rapid Communications in Mass Spectrometry, 18, 1245 1249.
2. Death, A.K., McGrath, K.C.Y., Kazlauskas, R. Handelsman, D.J. (2004) Tetrahydrogestrinone is a potent androgen and progestin. Journal of Clinical Endocrinology and Metabolism, 89, 2498 2500.
3. FDA US Food and Drug Administration. October 28 2003). FDA statement on THG. Available at http://www.fda.gov/bbs/topics/NEWS/2003/NEW00967.html [accessed February 27, 2008].
4. FDA US Food and Drug Administration 1996). FDA Guidance for Industry Q2B Validation of Analytical Procedures: Methodology. Available at: http://www.fda.gov/Cder/Guidance/1320fnl.pdf [accessed Jun. 22, 2008].
5. Friedel, A., Geyer, H., Kamber, M., Laudenbach-Leschowsky, U., Schänzer, W., Thevis, M., Vollmer, G., Zierau, O. Diel, P. (2006) Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver. Toxicology Letters, 164, 16 23.
6. Gerlach, M. (2005) Untersuchung zur Pharmakokinetik des Stoffes Tetrahydrogestrinon hinsichtlich der Dopingrelevanz beim Pferd. Dissertation. Stiftung Tierärztliche Hochschule Hannover, 24 25.
7. Houghton, E. Dumasia, M.C. (1980) Studies related to the metabolism of anabolic steroids in the horse: The identification of some 16-oxygenated metabolites of 19-nortestosterone. Xenobiotica, 10, 381 390.
8. Jasuja, R., Catlin, D.H., Miller, A., Chang, Y.C., Herbst, K.L., Starkevic, B., Artaza, J.N., Singh, R., Datta, G., Sarkissian, A., Chandsawangbhuwana, C., Baker, M. Bhasin, S. (2005) Tetrahydrogestrinone is an androgenic steroid that stimulates androgen receptor-mediated, myogenic differentiation in C3H10T1/2 multipotent mesenchymal cells and promotes muscle accretion in orchidectomized male rats. Endocrinol., 146, 4472 4478.
9. Labrie, F., Luu-The, V., Calvo, E., Martel, C., Cloutier, J., Gauthier, S., Belleau, P., Morissette, J., Levesque, M.-H. Labrie, C. (2005) Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid. Journal of Endocrinology, 184, 427 433.
10. Levesque, J.-F., Templeton, E., Trimble, L., Berthelette, C. Chauret, N. (2005) Discovery, biosynthesis, and structure elucidation of metabolites of a doping agent and a direct analogue, tetrahydrogestrinone and gestrinone, using human hepatocytes. Analytical Chemistry, 77, 3164 3172.
11. Machnik, M., Düe, M., Parr, M., von Kuk, C. Schänzer, W. (2004a) Case study: doping substances in equestrian food supplements. Chromatographia, 59, 131 135.
12. Machnik, M., Thevis, M., von Kuk, C., Guddat, S. Schänzer, W. (2004b) Gestrinone analysis in equine urine by LC-MS/MS. In Recent advances in Doping Analysis (12) Eds Schänzer, W., Geyer, H., Gotzmann, A. Mareck, U., p 149 157. Sport & Buch Strauß, Cologne.
13. Schänzer, W. (1996) Metabolism of anabolic androgenic steroids. Clinical Chemistry, 42, 1001 1020.
14. Stanley, S.M., Smith, L. Rodgers, J.P. (1997) Biotransformation of 17-alkylsteroids in the equine: gaschromatographic - mass spectral identification of ten intermediate metabolites of methyltestosterone. Journal of chromatography. B, 690, 55 64.
15. Thevis, M., Bommerich, U., Opfermann, G. Schänzer, W. (2005a) a) Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry. Journal of Mass Spectrometry and Ion Physics, 40, 494 502.
16. Thevis, M., Geyer, H., Mareck, U. Schänzer, W. (2005b) Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. Journal of Mass Spectrometry and Ion Physics., 40, 955 962.
17. WADA Editorial. The list of prohibited substances includes tetrahydrogestrinone. Septemper 22 2007). http://www.wada-ama.org/rtecontent/ document/2008-List-En.pdf [accessed Mar. 25, 2008].